- Home
- RPD vs BHC Comparison
RPD vs BHC Comparison
Compare RPD & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPD
- BHC
- Stock Information
- Founded
- RPD 2000
- BHC N/A
- Country
- RPD United States
- BHC Canada
- Employees
- RPD N/A
- BHC N/A
- Industry
- RPD Computer Software: Prepackaged Software
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- RPD Technology
- BHC Health Care
- Exchange
- RPD Nasdaq
- BHC Nasdaq
- Market Cap
- RPD 1.5B
- BHC 1.7B
- IPO Year
- RPD 2015
- BHC N/A
- Fundamental
- Price
- RPD $23.30
- BHC $4.53
- Analyst Decision
- RPD Hold
- BHC Hold
- Analyst Count
- RPD 19
- BHC 5
- Target Price
- RPD $32.94
- BHC $7.20
- AVG Volume (30 Days)
- RPD 927.9K
- BHC 1.5M
- Earning Date
- RPD 05-12-2025
- BHC 04-30-2025
- Dividend Yield
- RPD N/A
- BHC N/A
- EPS Growth
- RPD N/A
- BHC N/A
- EPS
- RPD 0.41
- BHC N/A
- Revenue
- RPD $849,159,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- RPD $3.09
- BHC $3.71
- Revenue Next Year
- RPD $4.29
- BHC $5.03
- P/E Ratio
- RPD $56.30
- BHC N/A
- Revenue Growth
- RPD 6.19
- BHC 8.53
- 52 Week Low
- RPD $21.61
- BHC $3.96
- 52 Week High
- RPD $44.48
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- RPD 41.94
- BHC 39.49
- Support Level
- RPD $22.12
- BHC $4.46
- Resistance Level
- RPD $23.05
- BHC $4.61
- Average True Range (ATR)
- RPD 0.67
- BHC 0.12
- MACD
- RPD -0.03
- BHC 0.03
- Stochastic Oscillator
- RPD 19.10
- BHC 26.32
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.